OptimizeRx Stock Scores Healthy Composite Rating
OptimizeRx saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. Is OptimizeRx stock on your watchlist? The new score indicates OptimizeRx is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.